Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Cistron Biotechnology(CIST)$.30 -- Ignore unavailable to you. Want to Upgrade?

To: Dr. John M. de Castro who wrote (1748)	12/2/1998 12:03:00 AM
From: rkrw	Read Replies (2) \| Respond to of 2742

John, Yes the results do look stunning. Fortunately, I don't allow my dog, Daisy, to fight with other dogs. But I am sure there is a large market for a quality wound healing product for the more aggressive and their more passive canine counterparts. Hopefully the NDA will be approved soon, so all those animals can heal in speedy fashion. Keep up the good work Cistron!

To: Dr. John M. de Castro who wrote (1748)	12/2/1998 7:50:00 AM
From: Dr. John M. de Castro	Read Replies (6) \| Respond to of 2742

CIST finally got around to putting out a press release on the Q1 results that have been on Edgar for 2 weeks. biz.yahoo.com What I am puzzled by is the continuing decline in the number of outstanding shares. The current report indicates that there are 22,983,687 shares outstanding as of 9/30/98. As of 6/30/98 there were 24,955,077 shares outstanding. What happened to the 1,971,390 shares. Is CIST engaging in Steve's buyback and not telling anyone or am I missing something her? John de C